Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moni Neradilek

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
International Orthopaedics|December 5, 2018
One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg: one thousand two hundred seventy individual patients from eleven centersFrederick A Matsen, Joseph P Iannotti, R Sean Churchill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 19, 2025
Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085Deborah A Theodore, Moni Neradilek, Kevin Gillespie, et al.
Frontiers in Immunology|April 10, 2026
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposuresAndrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, et al.
Open Forum Infectious Diseases|November 29, 2023
Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021Kathryn E Stephenson, Jasmine R Marcelin, Audrey E Pettifor, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Orthopaedics|December 5, 2018
One and two-year clinical outcomes for a polyethylene glenoid with a fluted peg: one thousand two hundred seventy individual patients from eleven centersFrederick A Matsen, Joseph P Iannotti, R Sean Churchill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 19, 2025
Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085Deborah A Theodore, Moni Neradilek, Kevin Gillespie, et al.
Frontiers in Immunology|April 10, 2026
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposuresAndrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, et al.
Open Forum Infectious Diseases|November 29, 2023
Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021Kathryn E Stephenson, Jasmine R Marcelin, Audrey E Pettifor, et al.
Pageof 3